|
Market Closed -
Euronext Paris
18:55:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.400 EUR | -6.93% |
|
+33.97% | -50.15% |
| 10-19 | Sensorion Announces Appointment of Peter Weber as Chief Medical Officer, Effective November 2, 2026 | CI |
| 10-19 | Sensorion rallies after appointment of chief medical officer |  |
Company Valuation: Sensorion
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 153.4 | 29.56 | 80.38 | 191 | 101.3 | 86.56 | - |
| Change | - | -80.74% | 171.97% | 137.65% | -47% | -14.51% | - |
| Enterprise Value (EV) 1 | 107.4 | 7.116 | 80.38 | 126.4 | 55.03 | 12.56 | 11.56 |
| Change | - | -93.38% | 1,029.56% | 57.22% | -56.45% | -77.17% | -7.96% |
| P/E | -10.1x | -1.28x | -2.53x | -7.07x | -3.37x | -2.51x | -3.75x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0x | 0.1x | 0.2x | -0.3x | 0.1x | 0.1x |
| Capitalization / Revenue | 35.3x | 5.9x | 14.1x | 28.7x | 17.4x | 18.6x | 5.44x |
| EV / Revenue | 24.7x | 1.42x | 14.1x | 19x | 9.47x | 2.69x | 0.73x |
| EV / EBITDA | -7.31x | -0.32x | -3.65x | -4.64x | -1.88x | -0.36x | -0.54x |
| EV / EBIT | -7.15x | -0.31x | -3.6x | -4.45x | -1.79x | -0.35x | -0.53x |
| EV / FCF | -9.56x | -0.31x | - | -5.74x | -2x | -0.47x | 7.86x |
| FCF Yield | -10.5% | -321% | - | -17.4% | -50% | -215% | 12.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -9.5 | -14.5 | -8.5 | -4.5 | -5 | -3.35 | -2.24 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 4.349 | 5.006 | 5.698 | 6.653 | 5.814 | 4.663 | 15.92 |
| EBITDA 1 | -14.69 | -22.37 | -22.04 | -27.24 | -29.31 | -34.95 | -21.55 |
| EBIT 1 | -15.02 | -23.14 | -22.31 | -28.4 | -30.75 | -35.4 | -21.93 |
| Net income 1 | -15.14 | -23.21 | -22.06 | -25.97 | -29.43 | -36 | -28.79 |
| Net Debt 1 | -46.02 | -22.44 | - | -64.66 | -46.22 | -74 | -75 |
| Reference price 2 | 96.300 | 18.500 | 21.500 | 31.800 | 16.850 | 8.400 | 8.400 |
| Nbr of stocks (in thousands) | 1,593 | 1,598 | 3,739 | 6,007 | 6,009 | 10,305 | - |
| Announcement Date | 4/28/22 A | 3/16/23 A | 2/29/24 A | 3/14/25 A | 3/17/26 A | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.51x | 2.69x | -0.36x | - | 96.93M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 7.93x | 26.43x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| Average | 23.84x | 24.07x | 14.10x | 0.32% | 38.32B | |
| Weighted average by Cap. | 26.71x | 25.31x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALSEN Stock
- Valuation Sensorion
Select your edition
All financial news and data tailored to specific country editions
